Galaxy Surfactants Ltd. · NSE:GALAXYSURF

Galaxy Surfactants — FY2025 Earnings Presentation

45 slides from Galaxy Surfactants's earnings presentation, May 16, 2025

  1. Slide 1: Galaxy Surfactants Ltd. exchange filing cover letter

    Galaxy Surfactants Ltd. May 16, 2025 National Stock Exchange of India Limited BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub: I

  2. Slide 2: Galaxy Surfactants Limited Investor Presentation - May'25

    " . � . +'3,,, ,....., h' i ,, ,, ,,.,�:\-. (f� __ ,. '' --c. ' ['\ >? , Galaxy Surfactants Limited P'd - to6at Sag±lie ta to6at 3ad Investor Presentation - May’25 I - A

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se

  4. Slide 4: Q4 & FY25 Performance Highlights

    Q4 & FY25 Performance Highlights

  5. Slide 5: FY25: Key Developments

    FY25: Key Developments Volume growth was low single digit for Q4FY25 and FY25 on YoY basis, EBITDA/MT for Q4FY25 stood at ₹21,715, an increase of 24% on QoQ and for FY25 was at ₹19,868, broadly in line with FY24 Record Quarterly volumes of ROW driven by masstige categories AMET volumes remains flat

  6. Slide 6: FY25 Consolidated Performance Highlights

    FY25 Consolidated Performance Highlights Rs. In Crores Total Revenue* EBITDA PAT +11.0% +2.5% +1.1% 4,249.5 497.7 510.0 301.5 304.9 3,829.8 FY24 FY25 FY24 FY25 FY24 FY25 *Includes other Income 5

  7. Slide 7: Q4FY25 Consolidated Performance Highlights

    Q4FY25 Consolidated Performance Highlights Rs. In Crores Total Revenue* EBITDA PAT +21.0% +7.3% -2.1% 1,152.7 134.7 77.5 75.9 1,045.7 125.6 952.9 109.5 64.6 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 *Includes other Income 6

  8. Slide 8: FY25 Segment Performance Highlights

    FY25 Segment Performance Highlights Segment-wise Revenue & Volume Performance Region-wise Volume Performance INDIA Performance Surfactants Revenue Flat vs Previous Year Rs. 2,590.8 cr Total Revenue + Specialty Care Revenue Rs. 4,249.5 cr AMET Flat vs Previous Year Rs. 1,658.6 Performance Surfactants

  9. Slide 9: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Particulars (Rs. In Crores) Q4FY25 Q4FY24 Y-o-Y Q3FY25 Q-o-Q FY25 FY24 Y-o-Y Net Revenue from Operations 1,144.9 929.0 23.2% 1,041.7 9.9% 4,223.7 3,794.4 11.3% Other Income 7.8 23.9 4.0 25.8 35.5 Total Revenue 1,152.7 952.9 21.0% 1,045.7 10.2% 4,249.5 3,829.8 11.

  10. Slide 10: Consolidated Balance Sheet

    Consolidated Balance Sheet Particulars (Rs. In Crores) Mar'25 Mar'24 Particulars (Rs. In Crores) Mar'25 Mar'24 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 839.8 825.1 EQUITY Right-of-use assets 184.3 140.4 Equity Share Capital 35.5 35.5 Capital work-in-progress 261.9 158.5 Other Equi

  11. Slide 11: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Particulars (Rs. In Crores) FY25 FY24 Cash Flow From Operating Activities : Profit After Tax 304.9 301.5 Operating Profit before working Capital changes 484.5 485.5 Net cash flows generated from/(used) in Operating Activities (A) 420.5 518.4 Net cash flows generated

  12. Slide 12: Standalone Profit & Loss Statement

    Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q4FY25 Q4FY24 Y-o-Y Q3FY25 Q-o-Q FY25 FY24 Y-o-Y Net Revenue from Operations 814.3 705.7 15.4% 727.3 12.0% 3,001.3 2,745.2 9.3% Other Income 6.7 4.4 5.5 26.5 24.0 Total Revenue 820.9 710.1 15.6% 732.9 12.0% 3,027.7 2,769.2 9.3% Cost of M

  13. Slide 13: Standalone Balance Sheet

    Standalone Balance Sheet Particulars (Rs. In Crores) Mar'25 Mar'24 Particulars (Rs. In Crores) Mar'25 Mar'24 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 553.5 526.5 EQUITY Right-of-use assets 145.4 101.0 Equity Share Capital 35.5 35.5 Capital work-in-progress ...... .· 253.9 : . 155.

  14. Slide 14: Standalone Cash Flow Statement

    Standalone Cash Flow Statement Particulars (Rs. In Crores) FY25 FY24 Cash Flow From Operating Activities : Profit After Tax 173.8 200.3 Operating Profit before working Capital changes 282.7 319.3 Net cash flows generated from/(used) in Operating Activities (A) 295.5 238.4 Net cash flows generated fr

  15. Slide 15: Business Overview

    q " Business Overview .. 14

  16. Slide 16: Truly Indian MNC…

    Truly Indian MNC… Leading manufacturer of Product applications across Preferred supplier to leading ingredients for Home and Mass, Masstige & Prestige Multinational, Regional & Brand Custodian Personal Care Industries range of Customers Local FMCG Brands Globally Recognized Integrated Across Full Ad

  17. Slide 17: …Vertically Integrated in HPC Industry

    …Vertically Integrated in HPC Industry r: 0 0 0 0 O o% €° . 3 0 0 0 i# 1· \ ~ . ..· X > 7 Strategically Located 215+ Product Grades Extensive R&D Capabilities Indigenous Facilities with Inhouse Project 100+ Members, R&D Centre, Intellectual Property Execution Capabilities Pilot Plant, Product Applic

  18. Slide 18: We grow faster than HPC FMCGs

    We grow faster than HPC FMCGs India’s Largest Manufacturer of Oleochemical based Surfactants and Specialty Care Products for Home Care and Personal Care Industries (HPC) Consumer to Innovation & Chemistry Technology 01 03 05 Global Supplier 02 Multiple 04 High Growth to Global Brands Products across

  19. Slide 19: Our growth trajectory over Three Decades

    Our growth trajectory over Three Decades Revenue (Rs in Crores) 1984: New Plant at Tarapur for 1994: New Plant set up at Tarapur 2004: Setting up of EOU at Taloja 2011: Commissioning of Egypt and Jhagadia Plants Ethoxylates, Phenoxyethanol, 1995: Acquisition of Galaxy 2009: 2014: Purchase of busines

  20. Slide 20: Our focus is Personal & Home Care Segment

    Our focus is Personal & Home Care Segment Hair Care Oral Care Home Care Shampoos Toothpaste Carpet Cleaner Conditioners Tooth powder Toilet Cleaner Colorants Mouth wash Detergents Styling Gels Fabric Cleaner Glass / Floor Cleaner Liquid Detergent Mass Mass -tige Prestige Serving needs across Consume

  21. Slide 21: Consumer Benefits: 215+ Product Offerings

    … with over 215+ Product Offerings . ✓ Foam and Dirt removal properties I I Anionic Surfactants FAES, FAS, LABSA Performance I I Surfactants Non-Ionics Surfactants Ethoxylates ✓ Cosmetics and Personal care products as emulsifiers and solubilisers Betaines ✓ Dermatological properties to reduces skin

  22. Slide 22: Our Business Segments…

    Our Business Segments… Performance Surfactants Specialty Care Products “Substantive Raw Material in Customer’s End-products” “Unique Functionality to Customer’s End-products” About Product ▪ Products are functional in nature where End- ▪ Niche & Premium products consumer require foaming & cleansing

  23. Slide 23: Our Global Footprints

    Our Global Footprints EE@en t €to6at Gads USA: TRI-K Industries-100% owned G Manufacturing ✓ ✓ @ R&D Netherlands USA em # Plants 1 h TRI K Industries o # Employees 75+ Global Headquarters o Egypt Galaxy Chemicals Marketing office ✓ Mexico (Egypt) S.A.E. India FY25: Revenue Breakup Egypt:100% owned*

  24. Slide 24: "Consumer to Chemistry": Creation of Products

    “Consumer to Chemistry”: Creation of Products Idea Stage 76 111 approved Patents and 32 applied / INDIA USA EUROPE ROW GLOBALLY r - - - - - - - - - - - - - - -. Feasibility Stage 25 21 11 10 Applied 32 New product Granted 5 • 111 Patents 32 Patents grades, • -------- .- - - - 0 Capability Stage «i s

  25. Slide 25: …with World-class R&D facilities

    …with World-class R&D facilities Collaborative product development with Customers which helps Customers in choosing “Right Technology with Right Application” Inhouse R&D Team of 100+ professionals comprising of doctorates, chemists and engineers Well-Equipped R&D Centre, Pilot Plant at Tarapur, Maha

  26. Slide 26: State-of-the-art Manufacturing Facilities

    State-of-the-art Manufacturing Facilities Location No. of Units Installed Capacity Details ] ✓ 1 pilot plant for scale up and commercialisation of new Tarapur, Maharashtra 3 34,747 MTPA asps± ✓ products rolling out from R&D activities Easy access to the Jawaharlal Nehru Port Trust, Navi Mumbai 1l Ta

  27. Slide 27: 1,500+ Clients across 80+ Countries

    1,500+ Clients across 80+ Countries Procter & Colgate Reckitt Unilever Dabur Gamble Palmolive Benckiser l Himalaya Henkel t Emami Loreal CavinKare & Many more… Long term strategic relationship with all of the top 10 customers Strict qualifications and extensive collaboration with customers for end-p

  28. Slide 28: Awards & Certifications

    Awards & Certifications: Won in the Past Decade “Best Supply Partner”, 2015 2018 “Winning through Award of Global Performance” for d2.so Long Standing Partner Award Recognition from Innovation” at the Partner U'OREAL L’Oréal Asia Pacific 2012 (Saa Best Reliable Partner Award to Win, 2012 Awards “Cer

  29. Slide 29: ESG Initiatives

    ESG Initiatives 28

  30. Slide 30: Environment

    Environment Water Stewardship • Ensuring the manufacturing units in India are Zero Liquid Discharge Units since 2017 • Aim to achieve ZLD at our Egypt location as well • Multiple water conservation projects like recycling, condensate recovery, steam recovery and have even incorporated several water

  31. Slide 31: Certified as 1.4X water positive

    Galaxy Surfactants Ltd. has been certified as 1.4X water positive Because businesses thrive only when communities thrive 30

  32. Slide 32: Achieved the status of being a water positive company

    Achieved the status of being a water positive company [ Commemorating World Water Day, 2022, Galaxy Surfactants emerged as among the few Indian companies to achieve water positive certification and become 1.4X water positive ) [ The certification was granted by DNV Business Assurance India Private L

  33. Slide 33: Social

    Social Employee Safety, Fair Labour Women Health & Well being Practices Empowerment • Implemented ISO 45001:2018 Occupational Health and • Laid down employee code of conduct • Set-up of forums for mentoring women employees Safety management system at various manufacturing (COC) applicable to all emp

  34. Slide 34: Corporate Governance

    Corporate Governance Ethics Risk Grievances Disclosures & Governance & Integrity Management Transparency @ @ @ @ @ '' '' '' ' '' ' '' '' '' '' ' ' '' • • ' ' ' ' '' ¢ ¢ ¢ • Board of directors • Code of conduct laid down • Formulated and • Employee welfare council • A dedicated ‘Investor constituted

  35. Slide 35: Corporate Governance

    Corporate Governance Governance Structure Shareholders Board of Directors Nomination & Corporate Social Stakeholder’s Risk Management Audit Committee Remuneration Responsibility Relationship Committee Committee Committee Committee Management Team Organization 34

  36. Slide 36: Board Members

    Board Members Mr. Natarajan K. Krishnan Mr. Vaijanath Kulkarni Managing Director Executive Director and COO • Associated with Company since 1993 • CWA, Advanced Management Program from Harvard Business School L------------------------------------------------------------------------------------------

  37. Slide 37: The 4 Cs: Our Core Strength

    The 4 Cs: Our Core Strength g COMPETITIVENESS CHARACTER Transparent & Open, Respect & Adhering to Global Quality Value People, Dreaming & Standards, Supplying Envisioning , Conducting Customers Globally, Agile & Business with Integrity Nimble Footedness e COMPETENCE COMFORT Respecting our Commitment

  38. Slide 38: Growth Strategy

    Growth Strategy 37

  39. Slide 39: Personal & Home Care: High Entry Barrier Businesses

    Personal & Home Care: High Entry Barrier Businesses Z @a@ to6at Sag±lie ta €to6at Gads @ Process Product Customers Wide spectrum of ingredients for - Chemical execution Engineering & inhouse project Consumer categories / needs Customer Centric Integrated solutions for the HPC FMCG Industry Meeting p

  40. Slide 40: Our Growth Vision

    Our Growth Vision Sales R&D and Customer Market Strategy Profitability Optimization Innovation Wallet share Improve Financial Increased focus on Continue to focus Increase Wallet Mutually Performance high margin on R&D and Share with Existing Complimentary through Sales products in both Product Inno

  41. Slide 41: Financial Performance

    Financial Performance . ctD � 40

  42. Slide 42: Managing Volatility in Raw Material Prices and Currency...

    Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 90.00 3,000 2,600 86.00 2,200 82.00 1,800 78.00 1,400 74.00 1,000 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LOR Source: RB

  43. Slide 43: Our Performance Highlights

    Our Performance Highlights Total Revenue (Rs. In Crs) EBITDA (Rs. In Crs) PAT (Rs. In Crs) +10% <) +6% {)r +6% 578 381 4,474 4,250 498 510 3,698 3,930 460 302 302 305 413 263 375 230 2,602 2,795 FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 EBITDA per tonn

  44. Slide 44: Our Financial Strength

    Our Financial Strength Debt/ Equity (x) Return on Equity (%) 0.4 24.7% 25.5% 20.2% 18.3% 0.2 0.2 13.8% 12.9% 0.1 n 0.1 0.1 FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 Cash Flow from Operating Activities (Rs in Crs) Return on Capital Employed (%) 573 25.2% 518 23.5% 23.0% 421 19.3% 36

  45. Slide 45: Thank You

    Thank Company : Investor Relations Advisors : You Z @a@y $GA8«etGo«h nisors to6at Sag±lde to (todat Gaud CIN No: L39877MH1986PLC039877 CIN - U74140MH2010PTC204285 Mr. Paritosh Srivastava Mr. Mandar Chavan / Mr. Rahul Agarwal Email: Paritosh.Srivastava@galaxysurfactants.com mandar.chavan@sgapl.net /

Galaxy Surfactants — FY2025 Earnings Presentation on 6ix